Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 2
1(20.0%)
5Total
N/A(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03767478Not ApplicableActive Not Recruiting

Neuromuscular Electrical Stimulation For The Treatment of Diabetic Neuropathy

Role: collaborator

NCT03850496Not ApplicableCompleted

DESIVI: Dosing of Electrical Stimulation in Venous Insufficiency

Role: collaborator

NCT02114307Not ApplicableCompleted

REVITIVE for the Treatment of Patients With Venous Insufficiency

Role: collaborator

NCT02007590Not ApplicableCompleted

Aerosure and Six Minute Walk Distance in Severe COPD

Role: lead

NCT01923753Phase 2Terminated

A Short-term Comparative Study of Aerosure for Airway Clearance in Patients With Cystic Fibrosis

Role: lead

All 5 trials loaded